FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $44,000 | -12.0% | 13,245 | -19.8% | 0.00% | – |
| Q3 2019 | $50,000 | +31.6% | 16,516 | +4.0% | 0.00% | – |
| Q2 2019 | $38,000 | -44.9% | 15,881 | -14.0% | 0.00% | – |
| Q1 2019 | $69,000 | +4.5% | 18,468 | +0.4% | 0.00% | – |
| Q4 2018 | $66,000 | -30.5% | 18,399 | +10.7% | 0.00% | -100.0% |
| Q3 2018 | $95,000 | +11.8% | 16,628 | -2.3% | 0.00% | 0.0% |
| Q2 2018 | $85,000 | -4.5% | 17,021 | -2.0% | 0.00% | 0.0% |
| Q1 2018 | $89,000 | -26.4% | 17,362 | -13.9% | 0.00% | 0.0% |
| Q4 2017 | $121,000 | +3.4% | 20,166 | -4.3% | 0.00% | 0.0% |
| Q3 2017 | $117,000 | +31.5% | 21,080 | +10.3% | 0.00% | 0.0% |
| Q2 2017 | $89,000 | -9.2% | 19,108 | -3.7% | 0.00% | 0.0% |
| Q1 2017 | $98,000 | -63.4% | 19,849 | -17.9% | 0.00% | -66.7% |
| Q4 2016 | $268,000 | +49.7% | 24,179 | +25.0% | 0.00% | +50.0% |
| Q3 2016 | $179,000 | +23.4% | 19,337 | -15.3% | 0.00% | 0.0% |
| Q2 2016 | $145,000 | -11.6% | 22,818 | -9.5% | 0.00% | 0.0% |
| Q1 2016 | $164,000 | -27.4% | 25,223 | -9.5% | 0.00% | -33.3% |
| Q4 2015 | $226,000 | – | 27,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,000,000 | $7,330,000 | 3.56% |
| Sio Capital Management, LLC | 336,286 | $2,465,000 | 1.69% |
| Opaleye Management Inc. | 285,000 | $2,089,000 | 1.03% |
| SENZAR ASSET MANAGEMENT, LLC | 864,408 | $6,336,111,000 | 0.92% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,350,847 | $9,902,000 | 0.74% |
| Ghost Tree Capital, LLC | 150,000 | $1,100,000 | 0.50% |
| PURA VIDA INVESTMENTS, LLC | 102,000 | $748,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $2,785,000 | 0.36% |
| J. Goldman & Co LP | 474,810 | $3,480,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $6,956,000 | 0.27% |